ipilimumablifileucelnivolumabLifileucel-induced
…en of nausea and vomiting was reported in patients treated with ipilimumab. 55From patient selection to TIL expansion: a comprehensive ove…
8articles mentioning drugs
33drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Lifileucel ×
Lifileucel
This drug is selected. Its supporting articles are shown below.
Articles mentioning Lifileucel
8 articles · page 1 of 1lifileucellifileucel-associatedpembrolizumabRipretinibDabrafenibEncorafenib
…05755Thomas SS, Gogas H, Hong YK, et al. Efficacy and safety of lifileucel, an autologous tumor-infiltrating lymphocyte cell therapy, and …
lifileucelmelanoma
…eried to evaluate post-marketing adverse events associated with lifileucel. All reports submitted from initial market availability through…
lifileuceladvanced melanomaMassachusetts General HospitalDana-Farber/Harvard Cancer CentermelanomaMass General Cancer Center Tumor Cartography Centeradoptive T cell therapyDr. Miriam and Sheldon G. Adelson Medical Research Foundation
…ls. Using scRNA-seq and TCR-seq data from patients treated with lifileucel,3 we confirmed that tumoricidal TIL express high levels of LTB,…
lifileucelsolid tumoursFood and Drug AdministrationTumour-infiltrating lymphocyte (TIL) therapy
… strategy for solid tumours. The recent accelerated approval of lifileucel by the Food and Drug Administration marks a significant milesto…
lifileucelafamitresgene autoleucelsarcomasmelanomasynovial sarcomaUS Food and Drug AdministrationCell therapyimmune checkpoint inhibitors
…he second approval of a cell therapy in a solid tumor following lifileucel in melanoma and demonstrated the potential of cell therapies in…
LifileucelIL-2metastatic melanomaNational Cancer Institutemetastatic epithelial cancersFDA
…noma. Clin Cancer Res 2021;27(19):5289-5298.Kwong MLM, Yang JC. Lifileucel: FDA-approved T-cell therapy for melanoma. Oncologist 2024;29(8…
IMA203nivolumabpembrolizumabipilimumablifileucelrelatlimabPRAMEmetastatic melanomacutaneous melanoma
…2 and Flu 30 mg/m2 x 4 days, followed by a one-time infusion of IMA203 (1-10x 109 TCR T cells), and low-dose IL-2 (1 M IU QD x5 days, …